Practices, Resources and Challenges in Parkinsons Disease Management in Asia: Movement Disorders in Asia Study Group Report

Mohamed Ibrahim N. Phuenpathom W. Jagota P. Bhidayasiri R. Pal P.K. Lin C.-H. Kukkle P.L. Hatano T. Lim S.-Y. Myrzayev Z. Shang H. Ong J.N. Rosales R.L. Youn J. Aldaajani Z. Mittal S.O. Nawi A.M. Ugawa Y.
February 2026 John Wiley and Sons Inc

Movement Disorders Clinical Practice
2026 #13 Issue 2 379 - 392 pp.

Background: The prevalence of Parkinsons disease (PD) is increasing markedly in Asia, highlighting the urgent need to understand the current practices and challenges in delivering comprehensive PD care in this region. Objectives: We aimed to determine the resources and facilities for comprehensive management of PD in Asia focusing on regions (South East Asia, Middle East, Indian Subcontinent, East Asia, and Central Asia) and income levels (high-income countries-HIC, upper middle-income countries-UMIC, lower middle-income countries-LMIC). Method: A survey-based questionnaire was deployed to the MDS affiliate societies or key neurologists in 32 countries in Asia. Results: Thirty countries/territories participated in the survey. HICs have better availability of and accessibility to most health care professionals. Central Asia has the lowest availability of and accessibility to health care professionals. PD nurses are least available (33.3%) and least easily accessible (6.7%). Levodopa and anticholinergics are the most available (100%), accessible (100%) and affordable (100%) antiparkinsonian medications. Device-aid therapies are more available and accessible in East Asian countries/territories, compared to other regions. Accessibility to allied health professionals is poor (43%). Genetic testing is available in 18 (60%) countries/territories, mostly in HIC (P = 0.031). Community engagement and public health awareness campaigns are available in 21 (70%) countries/territories. Brain bank is available in seven (24.1%) countries/territories, mostly in HIC. Telemedicine is utilized in 21 (70%) countries/territories. Conclusion: This is the first survey-based study to highlight regional and income-based disparities on infrastructures required for comprehensive PD care in Asia. Regional collaborations between HIC and MIC may address some of these disparities.

antiparkinsonian medications , Asia , Asian , comprehensive , health care professionals , infrastructure , Parkinsons disease

Text of the article Перейти на текст статьи

Neurology Unit, Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
Chulalongkorn Centre of Excellence for Parkinsons Disease and Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand
The Academy of Science, The Royal Society of Thailand, Bangkok, Thailand
Department of Neurology, National Institute of Mental Health & Neurosciences (NIMHANS), Bengaluru, India
Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan
Institute of Molecular Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan
Parkinsons Disease and Movement Disorders Clinic, Bengaluru, India
Center for Parkinsons Disease and Movement Disorders, Manipal Hospital, Bengaluru, India
Department of Neurology, Juntendo University Faculty of Medicine, Tokyo, Japan
Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
The Mah Pooi Soo & Tan Chin Nam Centre for Parkinsons & Related Disorders, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
International Institute of Postgraduate Education, Department of Neurology and Neurosurgery, Almaty, Kazakhstan
Department of Neurology, Laboratory of Neurodegenerative Disorders, Rare Diseases Center, West China Hospital, Sichuan University, Chengdu, China
Department of Neurosciences, Section of Neurology, Makati Medical Center, Makati, Philippines
Neuroscience Institute and Research Center for Health Sciences, University of Santo Tomas and Hospital, Manila, Philippines
Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
Neuroscience Center, Samsung Medical Center, Seoul, South Korea
Neuroscience Department, King Fahad Military Medical Complex, Dhahran, Saudi Arabia
Cleveland Clinic Abu Dhabi, Neurological Institute, Abu Dhabi, United Arab Emirates
Department of Community Health, Faculty of Medicine, University Kebangsaan Malaysia, Kuala Lumpur, Malaysia
Department of Human Neurophysiology, Faculty of Medicine, Fukushima Medical University, Fukushima, Japan

Neurology Unit
Chulalongkorn Centre of Excellence for Parkinsons Disease and Related Disorders
The Academy of Science
Department of Neurology
Department of Neurology
Institute of Molecular Medicine
Parkinsons Disease and Movement Disorders Clinic
Center for Parkinsons Disease and Movement Disorders
Department of Neurology
Division of Neurology
The Mah Pooi Soo & Tan Chin Nam Centre for Parkinsons & Related Disorders
International Institute of Postgraduate Education
Department of Neurology
Department of Neurosciences
Neuroscience Institute and Research Center for Health Sciences
Department of Neurology
Neuroscience Center
Neuroscience Department
Cleveland Clinic Abu Dhabi
Department of Community Health
Department of Human Neurophysiology

10 лет помогаем публиковать статьи Международный издатель

Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026